385 related articles for article (PubMed ID: 31838017)
1. Mechanical regulation of oligodendrocyte biology.
Makhija EP; Espinosa-Hoyos D; Jagielska A; Van Vliet KJ
Neurosci Lett; 2020 Jan; 717():134673. PubMed ID: 31838017
[TBL] [Abstract][Full Text] [Related]
2. Engineering biomaterial microenvironments to promote myelination in the central nervous system.
Unal DB; Caliari SR; Lampe KJ
Brain Res Bull; 2019 Oct; 152():159-174. PubMed ID: 31306690
[TBL] [Abstract][Full Text] [Related]
3. Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.
Zhang S; Zhu X; Gui X; Croteau C; Song L; Xu J; Wang A; Bannerman P; Guo F
J Neurosci; 2018 Feb; 38(7):1802-1820. PubMed ID: 29335358
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs in oligodendrocyte development and remyelination.
Ngo C; Kothary R
J Neurochem; 2022 Aug; 162(4):310-321. PubMed ID: 35536759
[TBL] [Abstract][Full Text] [Related]
5. The orphan G protein-coupled receptor GPR149 is a negative regulator of myelination and remyelination.
Suo N; He B; Cui S; Yang Y; Wang M; Yuan Q; Xie X
Glia; 2022 Oct; 70(10):1992-2008. PubMed ID: 35758525
[TBL] [Abstract][Full Text] [Related]
6. The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.
Duncan GJ; Manesh SB; Hilton BJ; Assinck P; Plemel JR; Tetzlaff W
Glia; 2020 Feb; 68(2):227-245. PubMed ID: 31433109
[TBL] [Abstract][Full Text] [Related]
7. A modified flavonoid accelerates oligodendrocyte maturation and functional remyelination.
Su W; Matsumoto S; Banine F; Srivastava T; Dean J; Foster S; Pham P; Hammond B; Peters A; Girish KS; Rangappa KS; Basappa ; Jose J; Hennebold JD; Murphy MJ; Bennett-Toomey J; Back SA; Sherman LS
Glia; 2020 Feb; 68(2):263-279. PubMed ID: 31490574
[TBL] [Abstract][Full Text] [Related]
8. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
9. Circulating factors that influence the central nervous system remyelination.
Saitoh SS; Tanabe S; Muramatsu R
Curr Opin Pharmacol; 2022 Feb; 62():130-136. PubMed ID: 34995894
[TBL] [Abstract][Full Text] [Related]
10. Seeing is believing: Identifying remyelination in the central nervous system.
Hill MFE; Cunniffe NG; Franklin RJM
Curr Opin Pharmacol; 2022 Oct; 66():102269. PubMed ID: 35926475
[TBL] [Abstract][Full Text] [Related]
11. Glutamate versus GABA in neuron-oligodendroglia communication.
Habermacher C; Angulo MC; Benamer N
Glia; 2019 Nov; 67(11):2092-2106. PubMed ID: 30957306
[TBL] [Abstract][Full Text] [Related]
12. R-Ras1 and R-Ras2 Are Essential for Oligodendrocyte Differentiation and Survival for Correct Myelination in the Central Nervous System.
Sanz-Rodriguez M; Gruart A; Escudero-Ramirez J; de Castro F; Delgado-García JM; Wandosell F; Cubelos B
J Neurosci; 2018 May; 38(22):5096-5110. PubMed ID: 29720552
[TBL] [Abstract][Full Text] [Related]
13. PARP1-mediated PARylation activity is essential for oligodendroglial differentiation and CNS myelination.
Wang Y; Zhang Y; Zhang S; Kim B; Hull VL; Xu J; Prabhu P; Gregory M; Martinez-Cerdeno V; Zhan X; Deng W; Guo F
Cell Rep; 2021 Oct; 37(1):109695. PubMed ID: 34610310
[TBL] [Abstract][Full Text] [Related]
14. Microenvironmental regulation of oligodendrocyte replacement and remyelination in spinal cord injury.
Alizadeh A; Karimi-Abdolrezaee S
J Physiol; 2016 Jul; 594(13):3539-52. PubMed ID: 26857216
[TBL] [Abstract][Full Text] [Related]
15. The adult oligodendrocyte can participate in remyelination.
Duncan ID; Radcliff AB; Heidari M; Kidd G; August BK; Wierenga LA
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11807-E11816. PubMed ID: 30487224
[TBL] [Abstract][Full Text] [Related]
16. mTORC2 Loss in Oligodendrocyte Progenitor Cells Results in Regional Hypomyelination in the Central Nervous System.
Dahl KD; Almeida AR; Hathaway HA; Bourne J; Brown TL; Finseth LT; Wood TL; Macklin WB
J Neurosci; 2023 Jan; 43(4):540-558. PubMed ID: 36460463
[TBL] [Abstract][Full Text] [Related]
17. Extrinsic Factors Driving Oligodendrocyte Lineage Cell Progression in CNS Development and Injury.
Baydyuk M; Morrison VE; Gross PS; Huang JK
Neurochem Res; 2020 Mar; 45(3):630-642. PubMed ID: 31997102
[TBL] [Abstract][Full Text] [Related]
18. Cytoskeletal Signal-Regulated Oligodendrocyte Myelination and Remyelination.
Miyata S
Adv Exp Med Biol; 2019; 1190():33-42. PubMed ID: 31760636
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte precursor cells as a therapeutic target for demyelinating diseases.
Skaper SD
Prog Brain Res; 2019; 245():119-144. PubMed ID: 30961866
[TBL] [Abstract][Full Text] [Related]
20. Pathological potential of oligodendrocyte precursor cells: terra incognita.
Yi C; Verkhratsky A; Niu J
Trends Neurosci; 2023 Jul; 46(7):581-596. PubMed ID: 37183154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
